dc.contributor.author Neyrinck, Audrey M
dc.contributor.author Possemiers, Sam
dc.contributor.author Druart, Celine
dc.contributor.author Cani, Patrice D
dc.contributor.author Delzenne, Nathalie M
dc.contributor.author Van de Wiele, Tom
dc.contributor.author De Backer, Fabienne
dc.contributor.author Larondelle, Yvan
dc.date.accessioned 2025-06-17T14:06:11Z
dc.date.available 2025-06-17T14:06:11Z
dc.date.issued 2011-06-09
dc.description.abstract Alterations in the composition of gut microbiota--known as dysbiosis--has been proposed to contribute to the development of obesity, thereby supporting the potential interest of nutrients targeting the gut with beneficial effect for host adiposity. We test the ability of a specific concentrate of water-extractable high molecular weight arabinoxylans (AX) from wheat to modulate both the gut microbiota and lipid metabolism in high-fat (HF) diet-induced obese mice.Mice were fed either a control diet (CT) or a HF diet, or a HF diet supplemented with AX (10% w/w) during 4 weeks. AX supplementation restored the number of bacteria that were decreased upon HF feeding, i.e. Bacteroides-Prevotella spp. and Roseburia spp. Importantly, AX treatment markedly increased caecal bifidobacteria content, in particular Bifidobacterium animalis lactis. This effect was accompanied by improvement of gut barrier function and by a lower circulating inflammatory marker. Interestingly, rumenic acid (C18:2 c9,t11) was increased in white adipose tissue due to AX treatment, suggesting the influence of gut bacterial metabolism on host tissue. In parallel, AX treatment decreased adipocyte size and HF diet-induced expression of genes mediating differentiation, fatty acid uptake, fatty acid oxidation and inflammation, and decreased a key lipogenic enzyme activity in the subcutaneous adipose tissue. Furthermore, AX treatment significantly decreased HF-induced adiposity, body weight gain, serum and hepatic cholesterol accumulation and insulin resistance. Correlation analysis reveals that Roseburia spp. and Bacteroides/Prevotella levels inversely correlate with these host metabolic parameters.Supplementation of a concentrate of water-extractable high molecular weight AX in the diet counteracted HF-induced gut dysbiosis together with an improvement of obesity and lipid-lowering effects. We postulate that hypocholesterolemic, anti-inflammatory and anti-obesity effects are related to changes in gut microbiota. These data support a role for wheat AX as interesting nutrients with prebiotic properties related to obesity prevention.
dc.description.spage e20944
dc.description.volume 6
dc.identifier.doi 10.1371/journal.pone.0020944
dc.identifier.handle 2078.1/84270
dc.identifier.handle 2078.1/104560
dc.identifier.handle 1854/LU-1857853
dc.identifier.issn 1932-6203
dc.identifier.openaire doi_dedup___:7ce2925bb4c6e32f94bd8fe181e604c1
dc.identifier.pmc PMC3111466
dc.identifier.pmid 21695273
dc.identifier.uri https://trapdev.rcub.bg.ac.rs/handle/123456789/763631
dc.openaire.affiliation UCLouvain
dc.openaire.collaboration 1
dc.publisher Public Library of Science (PLoS)
dc.rights OPEN
dc.rights.license CC BY
dc.source PLoS ONE
dc.subject Male
dc.subject BACTERIAL COMMUNITY
dc.subject Subcutaneous Fat - drug effects, metabolism
dc.subject Gene Expression Regulation - drug effects
dc.subject Mice
dc.subject Biological Markers - metabolism
dc.subject Bacteroides
dc.subject Linoleic Acids, Conjugated
dc.subject Linoleic Acids, Conjugated - metabolism
dc.subject Prevotella - physiology
dc.subject Cholesterol - blood
dc.subject Bifidobacterium - physiology
dc.subject INSULIN-RESISTANCE
dc.subject INTESTINAL BACTERIA
dc.subject GUT MICROBIOTA
dc.subject Q
dc.subject R
dc.subject CONJUGATED LINOLEIC-ACID
dc.subject Science General
dc.subject HEALTH-BENEFITS
dc.subject Intestines
dc.subject ADIPOSE-TISSUE
dc.subject Cholesterol
dc.subject Diet - adverse effects
dc.subject Medicine
dc.subject Research Article
dc.subject Science
dc.subject Triticum - chemistry
dc.subject LIPID-METABOLISM
dc.subject Dietary Fats - adverse effects
dc.subject Animals
dc.subject Obesity
dc.subject Intestines - drug effects, microbiology
dc.subject Xylans - chemistry, pharmacology, therapeutic use
dc.subject Body Weight
dc.subject Bacteroides - physiology
dc.subject IN-VITRO
dc.subject Dietary Fats
dc.subject Bacterial Load
dc.subject Metagenome - drug effects, physiology
dc.subject Obesity - diet therapy, etiology, metabolism, microbiology
dc.subject Diet
dc.subject Mice, Inbred C57BL
dc.subject Molecular Weight
dc.subject Body Weight - drug effects
dc.subject Prebiotics
dc.subject Bacterial Load - drug effects
dc.subject Gene Expression Regulation
dc.subject Metagenome
dc.subject GLUCOSE-TOLERANCE
dc.subject Bifidobacterium
dc.subject Insulin Resistance
dc.subject Biomarkers
dc.subject.fos 0301 basic medicine
dc.subject.fos 03 medical and health sciences
dc.subject.sdg 2. Zero hunger
dc.title Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice
dc.type publication

Collections

Loading...